TGEN
Tecogen Inc.
TGEN's outlook is improving, though it still trails on the overall score.
VRT
Vertiv Holdings Co
VRT has the edge over TGEN overall, supported by stronger fundamentals and stronger valuation.
TGEN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Unavailable |
TGEN's revenue is currently stable, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
TGEN PE Valuation
TGEN has no meaningful PE right now: it lost money over the past year.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT's PE is in its cheap range at 39x. If earnings grow as analysts expect, today's price would be 23x next year's earnings.
TGEN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect TGEN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
TGEN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.33 | -$0.12 |
| Q2 2026 | -$0.35 | -$0.17 |
| Q1 2026 | -$0.34 | -$0.16 |
| Q4 2025 | -$0.30 | -$0.11 |
| Q3 2025 | -$0.21 | +$0.01 |
| Q2 2025 | -$0.18 | +$0.02 |
| Q1 2025 | -$0.18 | -$0.01 |
| Q4 2024 | -$0.19 | $0.00 |
TGEN lost $0.33 per share over the past year, a bigger loss than the year before.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over TGEN on earnings quality, reporting a profit while its opponent remains loss making.
TGEN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.9M | +9.6% |
| Q2 2026 | $5.7M | -21% |
| Q1 2026 | $6.3M | -13% |
| Q4 2025 | $5.3M | -12% |
| Q3 2025 | $7.2M | +28% |
| Q2 2025 | $7.3M | +54% |
| Q1 2025 | $7.3M | +18% |
| Q4 2024 | $6.1M | +3% |
TGEN's revenue is down over the past year, though its latest quarter was up: $8M last quarter, up 9.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -20% | +9.4 points |
| Q2 2026 | -37% | -18 points |
| Q1 2026 | -34% | -26 points |
| Q4 2025 | -78% | -59 points |
| Q3 2025 | -29% | -14 points |
| Q2 2025 | -19% | +12 points |
| Q1 2025 | -8.2% | +8.8 points |
| Q4 2024 | -19% | +12 points |
TGEN's operating margin was −20% last quarter, up 9.4 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over TGEN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over TGEN on profitability, with a higher operating margin.
TGEN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.4M | +$2.2M |
| Q2 2026 | -$2.4M | +$321.5K |
| Q1 2026 | -$3.2M | -$1.8M |
| Q4 2025 | -$2.6M | -165% |
| Q3 2025 | -$3.6M | -$3.1M |
| Q2 2025 | -$2.7M | -$2.1M |
| Q1 2025 | -$1.3M | -1011% |
| Q4 2024 | $4M | +2126% |
TGEN has burned cash in most quarters: −$10M over the past year, against −$4M the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over TGEN on cash generation, producing positive trailing cash flow while its opponent burns cash.
TGEN Net Leverage
TGEN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has more cash than debt.
TGEN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.6 | Neutral |
| Stochastic | 12.3 | Oversold |
TGEN's weekly RSI is 38 (neutral) and its Stochastic is 12 (oversold).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
TGEN PE vs Industrials Sector
| Metric | TGEN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
TGEN has no meaningful PE right now: it lost money over the past year.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
TGEN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.28 | 2.6% below |
| 20 week MA | $3.02 | 26% below |
| 50 week MA | $3.94 | 44% below |
| 100 week MA | $4.64 | 52% below |
| 200 week MA | $2.78 | 20% below |
TGEN is in a downtrend: it's below all five of its weekly moving averages, and 20% below its 200-week average.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has the edge over TGEN on trend strength, trading above more of its moving averages.
TGEN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.26 | $1.17 | -48% |
| 2021 | $1.17 | $1.16 | -0.9% |
| 2022 | $1.16 | $1.21 | +4.3% |
| 2023 | $1.21 | $0.81 | -33% |
| 2024 | $0.81 | $1.45 | +79% |
| 2025 | $1.45 | $5.18 | +257% |
| 2026 YTD | $5.18 | $2.22 | -57% |
TGEN's yearly returns have swung widely, from +257% in 2025 to −48% in 2020. It's down 57% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over TGEN on returns for 2026, with the stronger performance.